These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 29687840

  • 41. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N, Hosseinpourfeizi MA, Khojasteh SMB, Baradaran B, Safaralizadeh R.
    Life Sci; 2020 Oct 15; 259():118239. PubMed ID: 32784058
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B, Lin N.
    Mol Cancer; 2014 Nov 26; 13():253. PubMed ID: 25424347
    [Abstract] [Full Text] [Related]

  • 49. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H, Jang JY, Kim PJ, Kim YG, Nam SJ, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK.
    Oncotarget; 2015 Jun 20; 6(17):15035-49. PubMed ID: 25909227
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP, Lee CH, Ying TH, Lin CL, Lin CL, Hsueh JT, Hsieh YH.
    Oncotarget; 2015 Oct 06; 6(30):28851-66. PubMed ID: 26311737
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN, Zhu H, Li LP, Jin AY, Wang HQ.
    Eur Rev Med Pharmacol Sci; 2019 Sep 06; 23(18):7935-7942. PubMed ID: 31599418
    [Abstract] [Full Text] [Related]

  • 55. Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT.
    Zheng Z, Zhang Y, Zhang Z, Yang Y, Song T.
    Med Sci Monit; 2017 Mar 13; 23():1277-1285. PubMed ID: 28288092
    [Abstract] [Full Text] [Related]

  • 56. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
    Li X, Zhao J, Yan T, Mu J, Lin Y, Chen J, Deng H, Meng X.
    J Food Sci; 2021 Jun 13; 86(6):2700-2712. PubMed ID: 33908630
    [Abstract] [Full Text] [Related]

  • 57. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
    Li GC, Cao XY, Li YN, Qiu YY, Li YN, Liu XJ, Sun XX.
    J Cell Physiol; 2018 Sep 13; 233(9):7379-7390. PubMed ID: 29575013
    [Abstract] [Full Text] [Related]

  • 58. [Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells].
    Zhang Y, Hao T, Zhang H, Wei P, Li X.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar 13; 34(3):247-252. PubMed ID: 29773107
    [Abstract] [Full Text] [Related]

  • 59. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis.
    Yao X, Yan C, Zhang L, Li Y, Wan Q.
    Medicine (Baltimore); 2018 Apr 13; 97(16):e0473. PubMed ID: 29668625
    [Abstract] [Full Text] [Related]

  • 60. [miR-34a-5p regulates viability, invasion and apoptosis of placental trophoblastic cells via modulating CDK6 and PI3K/AKT pathway].
    Li Q, Xu J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan 30; 40(1):79-86. PubMed ID: 32376568
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.